KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study - Bijal Shah; Armin Ghobadi; Olalekan O. Oluwole; Aaron C. Logan; Nicolas Boissel; Ryan D. Cassaday; Thibaut Leguay; Michael R. Bishop; Max S. Topp; Dimitrios Tzachanis; Kristen M. O’Dwyer; Martha Arellano; et al. (2021)